Department of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, AB, Canada.
Department of Non Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
J Clin Hypertens (Greenwich). 2018 Jun;20(6):984-990. doi: 10.1111/jch.13307. Epub 2018 May 22.
The Pan American Health Organization (PAHO)-World Hypertension League (WHL) Hypertension Monitoring and Evaluation Framework is summarized. Standardized indicators are provided for monitoring and evaluating national or subnational hypertension control programs. Five core indicators from the World Health Organization hearts initiative and a single PAHO-WHL core indicator are recommended to be used in all hypertension control programs. In addition, hypertension control programs are encouraged to select from 14 optional qualitative and 33 quantitative indicators to facilitate progress towards enhanced hypertension control. The intention is for hypertension programs to select quantitative indicators based on the current surveillance mechanisms that are available and what is feasible and to use the framework process indicators as a guide to program management. Programs may wish to increase or refine the number of indicators they use over time. With adaption the indicators can also be implemented at a community or clinic level. The standardized indicators are being pilot tested in Cuba, Colombia, Chile, and Barbados.
泛美卫生组织（PAHO）-世界高血压联盟（WHL）高血压监测和评估框架概述如下。为监测和评估国家或国家以下一级的高血压控制规划提供了标准化指标。建议在所有高血压控制规划中使用来自世界卫生组织心脏倡议的五个核心指标和一个泛美卫生组织-世界高血压联盟核心指标。此外，鼓励高血压控制规划从 14 个可选定性指标和 33 个定量指标中进行选择，以促进加强高血压控制的进展。其目的是让高血压规划根据现有的监测机制以及可行性来选择定量指标，并将框架过程指标作为规划管理的指南。规划可以考虑随着时间的推移增加或改进其使用的指标数量。经改编，这些指标也可以在社区或诊所层面实施。标准化指标正在古巴、哥伦比亚、智利和巴巴多斯进行试点测试。
